A decrease in irreversibly sickled erythrocytes in sicle cell anemia patients given vitamin E.
Patients with sickle cell anemia were given 450 IU of vitamin E (as alpha-tocopherol) per day for 6 to 35 weeks. Plasma tocopherol levels increased from 0.7 +/- 0.2 mg/g lipid pretreatment, to 2.3 +/- 0.3 mg/g lipid. The percentage of circulating irreversibly sickled red cells decreased from 25 +/- 3% pretreatment to 11 +/- 1% after vitamin E administration (P less than 0.001). The percentage of irreversibly sickled red cells remained below pretreatment levels as long as the vitamin was administered (up to 35 weeks). The biochemical and clinical implications of these observations are discussed.
D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D004913:Erythrocytes, Abnormal / Q000187:drug effects*; D005260:Female; D005319:Fetal Hemoglobin / Q000378:metabolism; D005838:Genotype; D006451:Hemoglobin, Sickle / Q000378:metabolism; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008297:Male; D024505:Tocopherols; D014810:Vitamin E / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use; D024502:alpha-Tocopherol / Q000031:analogs & derivatives*
D006451:Hemoglobin, Sickle; D006454:Hemoglobins; D014810:Vitamin E; D005319:Fetal Hemoglobin; D024502:alpha-Tocopherol; D024505:Tocopherols